1. Home
  2. ERNA vs UG Comparison

ERNA vs UG Comparison

Compare ERNA & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERNA
  • UG
  • Stock Information
  • Founded
  • ERNA 2018
  • UG 1942
  • Country
  • ERNA United States
  • UG United States
  • Employees
  • ERNA N/A
  • UG N/A
  • Industry
  • ERNA Biotechnology: Pharmaceutical Preparations
  • UG Package Goods/Cosmetics
  • Sector
  • ERNA Health Care
  • UG Consumer Discretionary
  • Exchange
  • ERNA Nasdaq
  • UG Nasdaq
  • Market Cap
  • ERNA 56.4M
  • UG 45.5M
  • IPO Year
  • ERNA N/A
  • UG N/A
  • Fundamental
  • Price
  • ERNA $0.27
  • UG $9.66
  • Analyst Decision
  • ERNA
  • UG
  • Analyst Count
  • ERNA 0
  • UG 0
  • Target Price
  • ERNA N/A
  • UG N/A
  • AVG Volume (30 Days)
  • ERNA 2.0M
  • UG 12.1K
  • Earning Date
  • ERNA 11-12-2024
  • UG 11-08-2024
  • Dividend Yield
  • ERNA N/A
  • UG 6.06%
  • EPS Growth
  • ERNA N/A
  • UG 38.11
  • EPS
  • ERNA N/A
  • UG 0.76
  • Revenue
  • ERNA $598,000.00
  • UG $12,312,275.00
  • Revenue This Year
  • ERNA N/A
  • UG N/A
  • Revenue Next Year
  • ERNA N/A
  • UG N/A
  • P/E Ratio
  • ERNA N/A
  • UG $13.01
  • Revenue Growth
  • ERNA 1072.55
  • UG 11.51
  • 52 Week Low
  • ERNA $0.26
  • UG $6.75
  • 52 Week High
  • ERNA $2.63
  • UG $16.25
  • Technical
  • Relative Strength Index (RSI)
  • ERNA 23.35
  • UG 36.52
  • Support Level
  • ERNA $0.26
  • UG $9.70
  • Resistance Level
  • ERNA $0.40
  • UG $9.95
  • Average True Range (ATR)
  • ERNA 0.06
  • UG 0.30
  • MACD
  • ERNA 0.01
  • UG 0.12
  • Stochastic Oscillator
  • ERNA 4.17
  • UG 22.85

About ERNA Eterna Therapeutics Inc.

Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: